Clarivate (CLVT) traded up 1.08 % during a 24 hours period ending at 04:55 PM Central Europe on Monday 26th. One Clarivate stock can currently be bought for about USD 1.81 on popular exchanges. Current supply of Clarivate stocks is 641.7 mn. Clarivate has a current market capitalization of USD 1.2 bn and approximately USD 7.3 mn worth of Clarivate was traded on exchanges in the last 24 hours. Since last month end, Clarivate has traded 1.63 % up. Simple moving average of last 200 days is at USD 2.26. The highest price of past 52 weeks was recorded at USD 3.87 on 11/28/2025. 52 weeks low was at USD 1.42 on 10/07/2026.
Here is how related stocks have performed in the past 24 hours:
Dar Global (DAR.L) traded up 0.15 % and now trades at USD 6.73. Dar Global has a market capitalisation of USD 1.2 bn. Dar Global PLC’s asset‑management arm, Dar Global Capital Partners, has announced a new strategic focus on high‑value real estate investments in Dubai and other major global markets. The platform, operating under the Dubai International Financial Centre’s regulatory framework, will deploy capital through a cross‑border mandate covering the GCC, Europe, the UK, and the United States. The firm emphasises disciplined entry valuations, robust downside protection, and active value creation via repositioning and operational improvements. In a move to strengthen governance, the company appointed its chief executive, Ziad El Chaar, as chairman of the asset‑management arm. This development follows Dar Global’s recent upgrade to an equity‑shares‑listed commercial entity on the London Stock Exchange and the expansion of its global portfolio to a significant gross development value. The strategy positions the company to leverage Dubai’s sustained appeal as a premier business and wealth hub while offering institutional‑grade access to international real‑estate opportunities.
Unilever (ULVR.L) traded down -0.76 % and now trades at GBX 4,928. Unilever has a market capitalisation of GBX 143.4 bn. Current price/earnings ratio for Unilever is 24.2. Unilever PLC’s shares have been among the retail‑heavy holdings that the author notes have been sold off in the recent period. The article describes how the author, who has liquidated positions in Unilever along with other consumer staples, has moved to a cash position to await potential market shifts. The narrative highlights a broader theme of retail investors being fully invested, with institutional managers trimming their exposure. The author’s strategy involves selling near 52‑week highs and adding short positions, suggesting a cautious stance toward the current market environment. No specific price figures are cited, but the emphasis is on the volatility and the need to remain flexible as the market potentially corrects. The piece reflects a broader view that retail sentiment is saturated and that cash reserves may be prudent until a clear reversal emerges.
Ferroglobe (GSM) traded down -0.99 % and now trades at USD 3.98. Current market capitalisation for Ferroglobe is USD 745.6 mn.
Biopharma Credit (BPCR.L) traded down -0.21 % and now trades at USD 0.98. Current market capitalisation for Biopharma Credit is USD 1.1 bn. Biopharma Credit has a current price to earnings ratio of 10.21.
Rio Tinto (RIO.L) traded flat 0 % and now trades at GBX 6,259. Current market capitalisation for Rio Tinto is GBX 135.6 bn. Rio Tinto has a current price to earnings ratio of 11.24. Rio Tinto’s share price experienced a modest decline during the reporting period, following a series of market‑wide adjustments. The metal‑mining giant’s valuation fell in line with broader fluctuations observed in the ASX scan list, where it appeared among stocks with a downward trend. The company’s performance indicators, such as earnings and cash flow, remain steady, and there were no announced changes to its operational strategy or dividend policy. Investors noted that Rio Tinto’s position within the sector continues to reflect its exposure to commodity cycles, while the company’s ongoing projects and portfolio diversification help to mitigate short‑term volatility. The market reaction was therefore moderate, with the share price moving slightly lower without signalling significant structural concerns.
About Clarivate
Clarivate PLC is a supplier of proprietary and comprehensive information, analytics, professional services, and workflow solutions. The company specializes in scientific and academic research, biopharma, medtech, IP intelligence, consultation, and data products and services. Clarivate has its operations base in London, UK and is listed on the New York Stock Exchange.
